Mazdutide research peptide
A once-weekly peptide that agonises both the GLP-1 receptor and the glucagon receptor.
Sizes, prices and availability
| Size | SKU | Stated purity | Batch COA | Price | Availability | |
|---|---|---|---|---|---|---|
| 10 mg | MZ10 | Not yet provided | Not yet provided | $51.99 | Out of stock |
Prices and stock are checked at build time and refreshed live in your browser. Orders are US only for a flat $24.95 shipping fee. Shipping details
About Mazdutide
Mazdutide is a dual agonist of the glucagon-like peptide-1 (GLP-1) receptor and the glucagon receptor, described in the literature as a once-weekly agent. Its published development has been largely in Chinese adult populations.
In receptor coverage it sits alongside survodutide (glucagon and GLP-1 receptors) and differs from tirzepatide (GIP and GLP-1 receptors) and retatrutide (GIP, GLP-1 and glucagon receptors).
What the published literature covers
- Zhang et al. (2024, Diabetes Care) report a randomised, placebo-controlled phase 2 trial in type 2 diabetes comparing mazdutide with placebo and open-label dulaglutide.
- Ji et al. (2025, New England Journal of Medicine) report once-weekly mazdutide in Chinese adults with obesity or overweight.
- Shirley (2025, Drugs) summarises the first regulatory approval.
Vial arithmetic
The peptide reconstitution calculator converts a vial size, diluent volume and target amount into concentration, syringe units and draws per vial. Volumes convert to syringe units with the syringe units converter. It does arithmetic only and does not suggest any amount.
FAQ
Which receptors does mazdutide act on?
Mazdutide is a dual agonist of the GLP-1 receptor and the glucagon receptor.
What sizes of Mazdutide does Covalume list?
Covalume lists Mazdutide in one size: 10 mg. Each size shows its price and live stock status in the variants table on this page.
How is the purity of Mazdutide documented?
Each listing shows the purity the supplier states, labelled (supplier), and the batch Certificate of Analysis field reads "Not yet provided" until a batch-specific document is on file. Our guide to reading a Certificate of Analysis explains what HPLC and mass-spectrometry results show.
References
- Zhang B, Cheng Z, Chen J, et al. (2024). Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. Diabetes Care 47:160-168. PubMed 37943529 · DOI
- Ji L, Jiang H, Bi Y, et al. (2025). Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight. N Engl J Med 392:2215-2225. PubMed 40421736 · DOI
- Shirley M (2025). Mazdutide: First Approval. Drugs 85:1621-1627. PubMed 41028652 · DOI
Identity values are from PubChem (CID 167312357) and the cited papers; for linear peptides the mass was also checked against the sequence. Last updated 2026-11-18.
Related research peptides
- Survodutide Dual glucagon and GLP-1 receptor agonist peptide
- Retatrutide Triple GIP, GLP-1 and glucagon receptor agonist peptide
- Tirzepatide Dual GIP and GLP-1 receptor agonist peptide
- Semaglutide GLP-1 receptor agonist peptide analogue
- All glp-1 research peptides
From the research library
- Peptide purity: HPLC and mass spectrometry explained
- Peptide reconstitution: concentration and volume math
- Semaglutide vs tirzepatide: structure and receptors
- Peptide purity vs peptide content: a vial mass balance
- Check the mass spectrometry on a COA yourself
- How to read a COA HPLC chromatogram
- HPLC vs LC-MS for peptides: identity and purity workflow
- How to read an LC-MS trace: a worked peptide example
- TFA to acetate: peptide counter-ion exchange
- Peptide net charge, pI and solubility by pH
- Peptide adsorption to vials and plastics
- How long do peptides last? Stability evidence explained
- Bacteriostatic water vs sterile water